These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27841771)

  • 1. Comprehensive management of hereditary hemorrhagic telangiectasia.
    Lupa MD; Wise SK
    Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):64-68. PubMed ID: 27841771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role.
    Hayama M; Maeda Y; Obata S; Tsuda T; Takeda K; Nishida T; Inohara H
    Auris Nasus Larynx; 2024 Apr; 51(2):305-312. PubMed ID: 38008660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).
    Alkhalid Y; Darji Z; Shenkar R; Clancy M; Dyamenahalli U; Awad IA;
    Vasc Med; 2023 Apr; 28(2):153-165. PubMed ID: 36890671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
    Sautter NB; Smith TL
    Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management].
    Frigerio C; Aebischer N; Baud D; Bonafe L; Fellmanne F; Ikonomidis C; Mazzolai L; Michel P; Nichita C; Qanadli SD; Lazor R
    Rev Med Suisse; 2016 May; 12(517):896-901. PubMed ID: 27323484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.
    Sautter NB; Smith TL
    Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) as an example of a rare disease relevant for oto-rhino-laryngology].
    Geisthoff UW; Maune S; Schneider G
    Laryngorhinootologie; 2011 Apr; 90(4):230-42; quiz 243-4. PubMed ID: 21523625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
    Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rendu-Osler-Weber disease].
    Sys L; van den Hoogen FJ
    Ned Tijdschr Tandheelkd; 2005 Sep; 112(9):336-9. PubMed ID: 16184912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy assessment of current treatment options for epistaxis in HHT.
    Dür C; Anschuetz L; Negoias S; Bulut OC; Angelillo-Scherrer A; Caversaccio M
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4321-4328. PubMed ID: 33661356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Albiñana V; Salcedo M; Señaris-Gonzalez B; Fernandez-Forcelledo JL; Botella LM
    Curr Vasc Pharmacol; 2010 Jul; 8(4):473-81. PubMed ID: 19485912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary hemorrhagic telangiectasia.
    Chung MG
    Handb Clin Neurol; 2015; 132():185-97. PubMed ID: 26564080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
    Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
    Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Hemorrhagic Telangiectasia Management.
    Peterson J
    Radiol Technol; 2017 Jan; 88(3):277-294. PubMed ID: 28298578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.
    Begbie ME; Wallace GM; Shovlin CL
    Postgrad Med J; 2003 Jan; 79(927):18-24. PubMed ID: 12566546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal Manifestations of Hereditary Hemorrhagic Telangiectasia (HHT): A Systematic Review of the Literature.
    Jackson SB; Villano NP; Benhammou JN; Lewis M; Pisegna JR; Padua D
    Dig Dis Sci; 2017 Oct; 62(10):2623-2630. PubMed ID: 28836046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.